Kingchem

What Kingchem does

Kingchem is a US-founded, vertically integrated small-molecule Contract Development and Manufacturing Organization (CDMO) established in 1994 and headquartered in Allendale, New Jersey. The company provides end-to-end development, custom synthesis, and manufacturing of active pharmaceutical ingredients (APIs), intermediates, regulated starting materials (RSMs), excipients, and specialty chemicals for pharmaceutical, agrochemical, electronic materials, and polyolefin catalyst customers globally. Its technology platform is differentiated by deep process chemistry expertise in fluorination (HF, KF, SF4), phosgenation, cryogenic reactions, heterocycle synthesis, and flow chemistry, supported by a 37-acre Fuxin manufacturing campus in China, a 40,000 sq ft Dalian R&D center staffed by 100 process chemists, and an FDA-registered cGMP facility in St. Francis, Wisconsin.

Kingchem operates a B2B enterprise sales model through PhD-level technical business development teams based in the US, China, and Germany, quoting project-specific fees and multi-year supply agreements that span clinical and commercial phases. Services are organized into GMP pharmaceutical manufacturing (APIs, intermediates, excipients at the Wisconsin site), non-GMP manufacturing (building blocks, fluorinated chemicals, heterocycles at the Fuxin site), and specialty chemical manufacturing (agrochemical, electronic materials, polyolefin catalysts, custom synthesis). Over 52% of pharmaceutical projects support Phase II–III and commercial-stage drugs, with products approved in more than 50 countries.

The company employs 501–1,000 people across the US and China and is publicly listed through its parent Kingchem Liaoning Life Science Co., Ltd. on the Shenzhen Stock Exchange (ticker: KSL, listed August 3, 2023), while remaining majority-owned and managed by US shareholders. Kingchem holds FDA registration (with a No Action Indicated cGMP inspection result in November 2024), a successful PMDA audit, ISO 9001, ISO 14001, ISO/IEC 17025, FSSC 22000, Kosher, and Halal certifications, and is currently executing a $30M+ expansion of its Wisconsin manufacturing campus, with $7M of investment planned in 2026 alone.

Name

Kingchem

Legal name

Kingchem Life Science LLC

Website

https://kingchem.com

Company type

Public

Founded year

1994

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Kingchem is a US-founded, vertically integrated small-molecule CDMO providing custom synthesis and GMP manufacturing of APIs, intermediates, excipients, and specialty chemicals for pharmaceutical, agrochemical, electronic materials, and polyolefin catalyst customers across 50+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing (CDMO)

NAICS

Pharmaceutical and Medicine Manufacturing (3254)

akta.pro primary industry

Small-Molecule API & Intermediates CDMO (HLAGABAA)

akta.pro secondary industries

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Pharmaceutical contract manufacturing
• API synthesis services
• Specialty chemical manufacturing
• Custom organic synthesis
• CGMP intermediates production

Headquarters

HQ city

Allendale

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Contract Development and Manufacturing Services: Kingchem generates revenue through CDMO services including process development, custom synthesis, and manufacturing of APIs, intermediates, RSMs, and specialty chemicals. Revenue is generated through project-based fees, manufacturing fees, and long-term supply agreements. Services span from early-stage clinical through commercial production with flexible engagement structures from single-project to multi-year partnerships.
2. Regulated Starting Materials (RSMs) Supply: Kingchem supplies regulated starting materials to pharmaceutical companies and other CDMOs supporting late-stage clinical and commercial programs. Often designated as preferred supplier within broader CDMO and pharmaceutical supply networks.
3. Specialty Chemical Manufacturing: Manufacturing of specialty chemicals for agrochemical, electronic materials, and polyolefin catalyst industries. Scale from kilogram to over 1,000 metric tons for commercial requirements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Kingchem is a global Contract Development and Manufacturing Organization (CDMO) providing end-to-end development and manufacturing of small-molecule APIs, intermediates, regulated starting materials (RSMs), and specialty chemicals. Services span process R&D, custom synthesis, kilo-lab and pilot scale-up, commercial cGMP manufacturing, and analytical support, delivered from FDA-registered facilities in Wisconsin (USA) and large-scale manufacturing operations in Fuxin and Dalian (China). Customers include pharmaceutical companies, biotech firms, other CDMOs, and agrochemical, electronic materials, and polyolefin catalyst industries.

Product overview

Kingchem is a global Contract Development and Manufacturing Organization (CDMO) offering integrated pharmaceutical and specialty chemical manufacturing services through a network of facilities in the US and China. The company's product portfolio is organized into two main categories: Pharmaceutical Manufacturing (encompassing GMP Manufacturing Services for APIs, intermediates, and excipients at the Wisconsin facility, and Non-GMP Manufacturing Services for building blocks, fluorinated chemicals, and heterocycles at the China facility) and Specialty Chemical Manufacturing (including agrochemical building blocks, electronic materials, polyolefin catalyst building blocks, and custom chemical synthesis). The portfolio is supported by Advanced Capabilities including Process R&D, analytical services, cryogenic processing, distillation, and flow chemistry. Kingchem operates under three main corporate entities: Kingchem Life Science LLC (US headquarters), Kingchem Liaoning Life Science Co., Ltd. (China parent), and Kingchem Laboratories Inc. (GMP manufacturing in Wisconsin).

Differentiator

Problem solved

Functional benefit

Products and services

• GMP Manufacturing Services cGMP manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, and excipients at the FDA-registered facility in St. Francis, Wisconsin, including API synthesis, intermediate production, excipient formulation, analytical testing, and regulatory support. Target customers are pharmaceutical and biotech companies requiring clinical and commercial drug substance supply.
• API Manufacturing Active Pharmaceutical Ingredient synthesis and manufacturing in the USA from a cGMP-certified, FDA-audited facility. Services include process development, kilo-lab production, and pilot- to commercial-scale manufacturing for pharmaceutical customers requiring clinical and commercial API supply.
• Intermediate Manufacturing Custom cGMP intermediate and regulated starting material (RSM) manufacturing in the USA, including full analytical testing, production-scale liquid and solid isolation equipment, and strong distillation capabilities. Target customers are pharmaceutical companies and other CDMOs needing reliable intermediates for clinical and commercial programs.
• Excipient Manufacturing Custom excipient cGMP manufacturing and packaging focused on high-purity, high-quality requirements for pharmaceutical excipient projects, including bulk liquid and solids handling. Target customers are pharmaceutical companies requiring excipients for clinical and commercial formulations.
• Non-GMP Manufacturing Services Non-GMP manufacturing services for early-stage drug discovery and development, including building blocks, fluorinated chemicals, heterocycles, and custom synthesis at the Fuxin, China facility. Target customers are pharmaceutical and biotech R&D groups needing kilogram to metric-ton quantities for early development.
• Building Blocks Molecular fragments for custom synthesis including difficult chemistry such as fluorination (HF, KF, SF4), chlorination, phosgenation, hydrogenation, cryogenic reactions, and Grignard reactions, manufactured at scales from kilograms to 1,000 metric tons. Target customers are pharmaceutical, agrochemical, and specialty chemical R&D and manufacturing organizations.
• Fluorinated Chemicals Custom fluorinated chemical manufacturing using HF and SF4 chemistry, with dedicated equipment for R&D, kilo, and pilot manufacturing. Target customers are pharmaceutical companies developing fluorinated APIs (approximately 20% of newly approved drugs use fluorinated compounds) and other chemical industries needing fluorinated intermediates.
• Heterocycles Custom large-scale heterocycle synthesis including triazoles, carbazoles, and quinolines, using in-house technology for cost-effective and scalable manufacturing from kilogram to metric ton scale. Target customers are pharmaceutical and agrochemical companies requiring heterocyclic intermediates for drug discovery and development.
• Specialty Chemical Manufacturing Specialty chemical manufacturing including agrochemical building blocks, electronic materials, polyolefin catalyst building blocks, and custom chemical synthesis at the Fuxin, Liaoning facility in China. Target customers are agrochemical, electronic materials, and polymer catalyst manufacturers needing large-scale custom chemicals.
• Agrochemical Building Blocks Large-scale manufacturing of agricultural building blocks for herbicides, pesticides, and fungicides, with production quantities exceeding 1,000 metric tons and experience in fluorinated chemicals and heterocycle chemistry. Target customers are agrochemical companies requiring raw materials and intermediates for crop protection products.
• Electronic Materials Ultra-high purity molecules for advanced electronic materials including semiconductor, display, and energy storage applications, plus specialty coatings for enhanced conductivity, insulation, and corrosion resistance. Target customers are electronics industry manufacturers requiring advanced precursors and specialty coatings.
• Polyolefin Catalyst Building Blocks Custom synthesis of complex raw materials, fluorinated intermediates, heterocycles, and organometallic compounds for polyolefin catalyst components and polymer science applications. Target customers are polymer and plastics industry manufacturers needing catalyst components and activators.
• Custom Chemical Synthesis Tailored chemical synthesis solutions from initial consultation and route design through process optimization and scale-up, with capabilities including multi-step organic synthesis, chiral synthesis, air/moisture-sensitive reactions, and scale-up optimization. Target customers are pharmaceutical, agrochemical, electronic materials, and specialty chemical companies needing bespoke synthesis.
• Process R&D and Analytical Services Process development and optimization, analytical method development and validation, route scouting, and comprehensive testing including HPLC, GC, NMR, LC-MS, GC-MS, ICP-OES, DSC, and UV-Vis at the Dalian R&D center, plus Process Hazard Analysis (PHA), cryogenic capabilities, distillation (fractional and vacuum with up to 30 theoretical plates), flow chemistry, and API packaging services. Target customers are pharmaceutical and specialty chemical companies requiring process and analytical support.

Quantifiable outcome

• Zero FDA 483 observations in November 2024 cGMP surveillance inspection
• +4 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Pharmaceutical Companies (General)coreOthersKingchem maintains collaborative relationships with pharmaceutical companies for drug development and manufacturing services. These partnerships are based on trust, transparency, and open communication, with Kingchem providing comprehensive services from R&D through commercial manufacturing.
• Research Institutions (General)minorStrategic or Co-development PartnerKingchem collaborates with research institutions that share commitment to innovation, quality, and excellence in scientific advancement and drug development.
• Material Suppliers (General)minorOthersKingchem partners with suppliers of critical materials to ensure reliable raw material sourcing and supply chain continuity for pharmaceutical and chemical manufacturing.
• PSCI (Pharmaceutical Supply Chain Initiative)minorOthersKingchem participates in PSCI audits, demonstrating commitment to ethical supply chain practices and sustainability in pharmaceutical manufacturing operations.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Piramal Pharma Solutions: Piramal is a large diversified contract manufacturer with significant small-molecule API capabilities in North America and Asia. It pursues similar late-stage and commercial API contracts as Kingchem's Wisconsin and Fuxin sites.
• Lonza Group: Lonza is the largest global CDMO offering small-molecule APIs among a broader portfolio including biologics and cell/gene therapy. While far larger and broader, Lonza competes with Kingchem for commercial API supply programs.

Direct peers

• Avista Pharma Solutions: Avista is a US-based small-molecule API CDMO under the Permira umbrella, with overlapping capabilities in complex synthesis, scale-up, and analytical services. King's CTO DiFranco also held senior roles at Avista before it merged into Cambrex.
• PharmaBlock Sciences: PharmaBlock is a Chinese-listed CDMO specializing in building blocks, intermediates, and APIs with similar fluorination and heterocycle capabilities. Several Kingchem business development staff moved from PharmaBlock, signaling direct technology and customer overlap.
• Siegfried Holding: Siegfried is a Swiss-listed small-molecule CDMO offering API and intermediate manufacturing with comparable scale and a similar Western-headquartered model. Kingchem's end-to-end API, intermediate, and RSM CDMO positioning closely mirrors Siegfried's vertically integrated drug-substance platform.
• Dottikon (Dottikon Exclusive Synthesis): Dottikon is a Swiss specialty CDMO focused on hazardous and complex small-molecule chemistry. Kingchem and Dottikon compete for the same high-potency and difficult-handling API contracts, and Kingchem has hired from Dottikon's business development team.
• WuXi STA (WuXi AppTec): WuXi STA is the dominant China-anchored small-molecule CDMO and a direct competitor in RSMs, intermediates, and APIs. Kingchem's Dalian R&D and Fuxin manufacturing platform competes head-to-head with WuXi STA's scale and chemistry portfolio.
• Cambrex: Cambrex (owned by Permira) is a US-headquartered small-molecule API and finished dosage CDMO with similar complex-chemistry focus. Kingchem competes for the same late-stage and commercial API tenders as Cambrex.
• AMPAC Fine Chemicals (SK pharmteco): SK pharmteco's AMPAC is a US-based small-molecule API CDMO with complex chemistry capabilities including phosgenation, cryogenics, and hazardous chemistries. Kingchem's CTO Elso DiFranco joined from AMPAC, underscoring direct technical and competitive overlap.

Emerging players

• BLD Pharmatech: BLD Pharmatech is a Chinese building-blocks and intermediates supplier with growing CDMO ambitions in fluorinated and heterocycle chemistry. It overlaps with Kingchem's non-GMP and early-GMP stages, particularly in catalog building blocks.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/kingchem-llc

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kingchem